コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mediated by the prototypical IRES element of encephalomyocarditis virus.
2 cation of poliovirus, coxsackievirus B3, and encephalomyocarditis virus.
3 ade up of two viral species, Theilovirus and Encephalomyocarditis virus.
4 g fibroblast cell line (104C1) infected with encephalomyocarditis virus.
5 mulation of viral proteins of poliovirus and encephalomyocarditis virus.
6 ters of vesicular stomatitis virus (VSV) and encephalomyocarditis virus.
7 siae, Pseudomonas aeruginosa, adenovirus, or encephalomyocarditis virus.
8 ival postinfection with either HSV type 1 or encephalomyocarditis virus.
9 ubiquitin-protein ligases that recognize the encephalomyocarditis virus 3C protease as a substrate we
13 cloned under the control of T7 promoter and encephalomyocarditis virus 5'-untranslated region (EMCV-
17 l diarrhea virus; and two unrelated viruses, encephalomyocarditis virus and cricket paralysis virus.
20 mice and cells are resistant to infection by encephalomyocarditis virus and SARS-CoV-2 because of enh
23 of foot-and-mouth disease virus, rhinovirus, encephalomyocarditis virus, and hepatitis A virus) are m
24 h after infection with rhinovirus type 1a or encephalomyocarditis virus, but the protein was stable i
26 rimary polyprotein cleavage, were created in encephalomyocarditis virus cDNA, expressed, and characte
27 IRES elements of Sabin type 1 poliovirus or encephalomyocarditis virus, confirming the low activity
29 se fibroblasts in response to infection with encephalomyocarditis virus (ECMV), a picornavirus that r
30 viroporin activity of influenza virus M2 or encephalomyocarditis virus (EMCV) 2B protein triggers tr
33 at different nononcogenic viruses, including encephalomyocarditis virus (EMCV) and human parainfluenz
34 y induced by herpes simplex virus 1 (HSV-1), encephalomyocarditis virus (EMCV) and influenza A virus
36 at QC suppresses translation directed by the encephalomyocarditis virus (EMCV) and poliovirus IRESs i
37 th no apparent role in cell-free systems for encephalomyocarditis virus (EMCV) and Theiler's murine e
38 We show here that two other RNA viruses, encephalomyocarditis virus (EMCV) and vesicular stomatit
43 e of this pathway in vivo, we studied murine encephalomyocarditis virus (EMCV) infection in mice and
44 tibody-independent protection against lethal encephalomyocarditis virus (EMCV) infection in the natur
45 ntiviral activity was investigated following encephalomyocarditis virus (EMCV) infection of cell line
48 ritical for their replication, the impact of encephalomyocarditis virus (EMCV) infection on the host
51 entire PV 5' noncoding region (NCR) with the encephalomyocarditis virus (EMCV) internal ribosomal ent
52 [aa] 613 to 1090) binds eIF3, eIF4A, and the encephalomyocarditis virus (EMCV) internal ribosomal ent
53 replication of chimeric RNAs containing the encephalomyocarditis virus (EMCV) internal ribosome entr
54 since Vhs cuts circular mRNAs containing an encephalomyocarditis virus (EMCV) internal ribosome entr
55 lete separation of E2 and p7 by inserting an encephalomyocarditis virus (EMCV) internal ribosome entr
56 S2/C113S mutant was restored by inserting an encephalomyocarditis virus (EMCV) internal ribosome entr
57 These data suggest that insertion of the encephalomyocarditis virus (EMCV) IRES element between t
58 inhibition of a cap-dependent luciferase or encephalomyocarditis virus (EMCV) IRES luciferase report
63 which the internal ribosome entry (IRES) for encephalomyocarditis virus (EMCV) is positioned between
65 tudy, potential cellular enzymes involved in encephalomyocarditis virus (EMCV) L-directed Nup phospho
66 investigated the suitability of the porcine encephalomyocarditis virus (EMCV) model for such studies
69 A5 RNA-agonist stimulation or infection with encephalomyocarditis virus (EMCV) or West Nile virus.
72 the internal ribosomal entry site (IRES) of encephalomyocarditis virus (EMCV) which mediates initiat
74 LGP2/RNA complexes from cells infected with encephalomyocarditis virus (EMCV), a picornavirus detect
75 sicular stomatitis virus, a Rhabdovirus, and encephalomyocarditis virus (EMCV), a picornavirus of the
76 ficient mice exposed to extracellular dsRNA, encephalomyocarditis virus (EMCV), and herpes simplex vi
77 ffect from Vesicular stomatitis virus (VSV), Encephalomyocarditis virus (EMCV), and Reovirus-3 virus
78 ISPR deletion of TNK2, WASL, or NCK1 reduced encephalomyocarditis virus (EMCV), coxsackievirus B3 (CV
79 2 internal ribosomal entry sites (IRESs) of encephalomyocarditis virus (EMCV), foot-and-mouth diseas
82 viruses (D(T)), such as adenovirus (Adeno), encephalomyocarditis virus (EMCV), influenza virus (H1N1
83 iruses, vesicular stomatitis virus (VSV) and encephalomyocarditis virus (EMCV), may also activate the
85 ice and show that upon lethal challenge with encephalomyocarditis virus (EMCV), which is sensed by MD
86 we have shown that NF-kappaB is required for encephalomyocarditis virus (EMCV)- and dsRNA-stimulated
87 t mice lacking ADAM9 are more susceptible to encephalomyocarditis virus (EMCV)-induced death and fail
88 hat the iPLA2beta-selective (S)-BEL inhibits encephalomyocarditis virus (EMCV)-induced iNOS expressio
93 control IRESs from both human rhinovirus and encephalomyocarditis virus exhibited strong IRES activit
96 nd control mice systemically challenged with encephalomyocarditis virus had similar mortality; howeve
97 e amino terminus of the required element for encephalomyocarditis virus has now been mapped to includ
99 were resistant to viral pathogens, including encephalomyocarditis virus, human rhinovirus, and respir
100 ibited the replication of vaccinia virus and encephalomyocarditis virus in cell culture, suggesting t
101 mpaired IFNalpha-mediated protection against encephalomyocarditis virus infection and reversal of IFN
104 in two different contexts, cap-mediated and encephalomyocarditis virus internal ribosomal entry site
105 n in several bicistronic messages having the encephalomyocarditis virus internal ribosome entry site
106 resistance gene, MDR1 linked together by the encephalomyocarditis virus internal ribosome entry site
107 ame of the reporter gene was preceded by the encephalomyocarditis virus internal ribosome entry site,
108 re inhibited by interferon treatment, but an encephalomyocarditis virus internal ribosome entry site-
110 ural proteins (NS3 to NS5B) was driven by an encephalomyocarditis virus internal ribosome entry site.
111 ivity comparable to that of a variant of the encephalomyocarditis virus IRES element in a context-ind
112 cifically to a structural element within the encephalomyocarditis virus IRES upstream of the initiati
113 hat obtained by using the well characterized encephalomyocarditis virus IRES when tested in the same
114 etion mutations into the J-K elements of the encephalomyocarditis virus IRES, translationally defecti
118 al resistance to infection with picornavirus encephalomyocarditis virus is known to require CD1d-depe
119 how that frameshifting in a model RNA virus, encephalomyocarditis virus, is trans-activated by viral
120 similarity to a circularly permuted form of encephalomyocarditis virus J-K domain, suggesting a cons
122 transcription in vivo during infection with encephalomyocarditis virus or transfection with poly(I:C
124 Furthermore, RNA from cells infected with encephalomyocarditis virus or with vaccinia virus and pr
125 ternal ribosome entry site (IRES) element of encephalomyocarditis virus picornavirus have been invest
126 ve reconstituted IRES-mediated initiation on encephalomyocarditis virus RNA from purified components
127 ranslation from another unrelated IRES (from encephalomyocarditis virus RNA), but did not affect the
128 ed to prevent diabetes in mice infected with encephalomyocarditis virus strain D (EMCV-D), which has
129 lpha and was protective against infection by encephalomyocarditis virus, suggesting an alternative in
130 N production in response to infection by the encephalomyocarditis virus, the replication of which act
132 ion and identified putative IRES elements in encephalomyocarditis virus, vascular endothelial growth
133 alpha against several RNA viruses, including encephalomyocarditis virus, vesicular stomatitis virus,
134 ey mesangial cells, as opposed to podocytes, encephalomyocarditis virus, vesicular stomatitis virus,
135 ruses such as vesicular stomatitis virus and encephalomyocarditis virus was not inhibited by IFN-beta
136 ibosome entry site (IRES) of a picornavirus, encephalomyocarditis virus, was used instead of the seco
137 of responses to dsRNA [poly(I).poly(C)] and encephalomyocarditis virus were greatly enhanced by IFN-
138 type 1 (e.g., poliovirus) and type 2 (e.g., encephalomyocarditis virus), which are dissimilar except